Humana (HUM) Tops Q4 EPS by 6c, Offers FY21 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Humana (HUM) PT Raised to $450 at Cantor Fitzgerald
February 3, 2021 12:30 PM ESTCantor Fitzgerald analyst Steven Halper raised the price target on Humana (NYSE: HUM) to $450.00 (from $440.00) while maintaining an Overweight rating.
The analyst commented, "We reiterate our OW rating on HUM and increase our price target to $450 from $440. On Wednesday, February 3, Humana reported better-than-expected 4Q20... More
